Participation in three consecutive mass drug administrations in Leogane, Haiti
Summary Objectives In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently tran...
Gespeichert in:
| Veröffentlicht in: | Tropical medicine & international health 2006-06, Vol.11 (6), p.862-868 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 868 |
|---|---|
| container_issue | 6 |
| container_start_page | 862 |
| container_title | Tropical medicine & international health |
| container_volume | 11 |
| creator | Mathieu, Els Direny, Abdel N. De Rochars, Madsen Beau Streit, Thomas G. Addiss, David G. Lammie, Patrick J. |
| description | Summary
Objectives In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non‐compliant and factors associated with this behaviour.
Methods We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non‐compliance and associated factors and (3) an urban survey to make a rural–urban comparison.
Results During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4–82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0–66.7), 61.0% (95% CI 55.0–67.4) and 67.3% (95% CI 60.5–74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P 14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
Conclusion More research is needed to identify characteristics of systematically non‐compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
Objectifs Dans l'effort global d’élimination de la filariose lymphatique, des administrations massives de médicament ont été organisées annuellement. Le succès de cette stratégie dépend de l'atteinte d'un haut niveau de l’étendue de couverture médicamenteuse, ce qui réduira le nombre de personnes porteuses de microfilaires circulant et par conséquent réduira la transmission de la maladie. Les personnes qui ne participant pas à ces administrations massives de médicaments représentent une menace potentielle pour le but de l’élimination de la filariose. Nous avons voulu connaître l’étendue de la couverture médicamenteuse, la proportion de personnes systématiquement non compliantes et les facteurs associés au comportement de non compliance.
Méthodes Nous avons |
| doi_str_mv | 10.1111/j.1365-3156.2006.01626.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_215507866</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1050065701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4746-8dee7a0cef52dccd1f3f171085b6c7c2c3e2ea224ecd09f8f30d187955217c9b3</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EolD4CyhCYiPBdmI7HRhQBbRS-RjKbLn2pThqkmIn0P57kjaiK7fcSX7eO-tBKCA4Im3d5RGJOQtjwnhEMeYRJpzyaHOEzv4ejnczDikVfIDOvc8xxknC-CkaEC5Em0vP0Ou7crXVdq1qW5WBLYP60wEEuio96Ka23xAUyvvAuGYZKFPY0vra7Wjf4TOolqqE22CibG0v0EmmVh4u-z5EH0-P8_EknL09T8cPs1AnIuFhagCEwhoyRo3WhmRxRgTBKVtwLTTVMVBQlCagDR5laRZjQ1IxYowSoUeLeIiu93vXrvpqwNcyrxpXticlJYxhkXLeQuke0q7y3kEm184Wym0lwbLzKHPZ6ZKdLtl5lDuPctNGr_r9zaIAcwj24lrgpgeU12qVOVVq6w-cSCkjMW65-z33Y1ew_fcH5Pxl2k3xL1_pjkg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215507866</pqid></control><display><type>article</type><title>Participation in three consecutive mass drug administrations in Leogane, Haiti</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Mathieu, Els ; Direny, Abdel N. ; De Rochars, Madsen Beau ; Streit, Thomas G. ; Addiss, David G. ; Lammie, Patrick J.</creator><creatorcontrib>Mathieu, Els ; Direny, Abdel N. ; De Rochars, Madsen Beau ; Streit, Thomas G. ; Addiss, David G. ; Lammie, Patrick J.</creatorcontrib><description>Summary
Objectives In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non‐compliant and factors associated with this behaviour.
Methods We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non‐compliance and associated factors and (3) an urban survey to make a rural–urban comparison.
Results During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4–82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0–66.7), 61.0% (95% CI 55.0–67.4) and 67.3% (95% CI 60.5–74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the population >14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
Conclusion More research is needed to identify characteristics of systematically non‐compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
Objectifs Dans l'effort global d’élimination de la filariose lymphatique, des administrations massives de médicament ont été organisées annuellement. Le succès de cette stratégie dépend de l'atteinte d'un haut niveau de l’étendue de couverture médicamenteuse, ce qui réduira le nombre de personnes porteuses de microfilaires circulant et par conséquent réduira la transmission de la maladie. Les personnes qui ne participant pas à ces administrations massives de médicaments représentent une menace potentielle pour le but de l’élimination de la filariose. Nous avons voulu connaître l’étendue de la couverture médicamenteuse, la proportion de personnes systématiquement non compliantes et les facteurs associés au comportement de non compliance.
Méthodes Nous avons mené trois enquêtes à la suite de la troisième administration de masse annuelle de médicament d'un programme d’élimination de la filariose à Leogane en Haïti: 1) enquête sur la population totale pour déterminer l’étendue de la couverture, 2) enquête chez les adultes pour déterminer la non compliance et les facteurs associés et 3) enquête urbaine pour une comparaison entre le milieu rurale et urbain.
Résultats Au cours de la 3ieme administration en masse de médicament, la couverture totale était de 78,5% (IC95%: 74,4–82,6). Une enquête dans lapopulation adulte a révèle une couverture chez les plus de 14 ans estimée respectivement à 59,4% (IC95%: 52,0–66,7), 61,0% (IC95%: 55,0–67,4) et 67,3% (IC95%: 60,5–74,0) pour la 1ere, 2ieme et 3ieme administration en masse de médicament. La couverture dans les zones rurales (78,3%) était significativement plus élevée que dans les zones urbaines (68,3%, p < 0,05). 18% des plus de 14 ans n'avaient jamais pris les médicaments quelle que soit l'année. Ces derniers n’étaient pas significativement différents des autres participants par l’âge, le sexe ou autres caracteristiques évaluées.
Conclusion Des études supplémentaires sont nécessaires pour identifier les caracteristiques des personnes systématiquement non compliantes afin d'affiner les messages d’éducation et d'améliorer les stratégies de distribution pour augmenter l’étendue de la couverture.
Objetivos Como parte del esfuerzo global para eliminar la filariasis linfática, anualmente se organizar administraciones masivas de medicamentos (AMM). El éxito de esta estrategia depende del poder alcanzar niveles altos de cobertura de los medicamentos, que reduzcan el número de personas que circulan con microfilarias y por ende, la transmisión. Las personas que consistentemente fallan en participar de las AMM representan una amenaza potencial al objetivo de eliminar la filariasis. Queríamos averiguar cual era la cobertura de medicamentos, la proporción de personas que sistemáticamente no cumplían y los factores asociados a este comportamiento.
Métodos Se realizaron 3 encuestas tras la tercera AMM anual del programa para la eliminación de la filariasis, en Leogane, Haiti: 1/encuesta a la población total con el fin de determinar la cobertura 2/encuesta entre los adultos para determinar falta de cumplimiento y factores asociados y 3/encuesta urbana para establecer una comparación rural‐urbana.
Resultados Durante la tercera AMM, la cobertura total entre los encuestados fue del 78.5% (95% intervalo de confianza (IC) 74.4–82.6). Una encuesta entre la población adulta mostró estimativos de cobertura para mayores de 14 años del 59.4% (95% IC 52.0–66.7), 61.0% (95% CI 55.0–67.4) y 67.3% (95% CI 60.5–74.0), para el primer, segundo y tercer AMM respectivamente. La cobertura en áreas rurales (78.3%) fue significativamente mayor que en áreas urbanas (68.3%, p < 0.05). De la población < 14 años, el 18% no tomó medicamentos durante ninguna de las tres AMM. Estas personas no eran significativamente diferentes de quienes sí participaban de las AMM ni en edad, género o cualquier otra característica evaluada.
Conclusiones Se requieren más estudios para identificar las características de personas sistemáticamente no cumplidoras, con el fin de redefinir los mensajes de educación en salud y para mejorar las estrategias de distribución que aumenten la cobertura de medicamentos.</description><identifier>ISSN: 1360-2276</identifier><identifier>EISSN: 1365-3156</identifier><identifier>DOI: 10.1111/j.1365-3156.2006.01626.x</identifier><identifier>PMID: 16772008</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anthelmintics - adverse effects ; Anthelmintics - therapeutic use ; Biological and medical sciences ; Child ; Child, Preschool ; community‐based distribution ; Compliance ; Diseases caused by nematodes ; distribución basada en la comunidad ; distribution basée sur la communauté ; Drug therapy ; Elephantiasis, Filarial - drug therapy ; Elephantiasis, Filarial - epidemiology ; encuesta ; eradication ; erradicación ; Female ; Filariases ; filariasis linfática ; filariose lymphatique ; General aspects ; Haiti - epidemiology ; Health Knowledge, Attitudes, Practice ; Helminthic diseases ; Humans ; Infant ; Infectious diseases ; Lymphatic filariases ; lymphatic filariasis ; Male ; Medical sciences ; Middle Aged ; Parasitic diseases ; Patient Compliance - psychology ; Patient Education as Topic - methods ; Population Surveillance ; Public health ; Rural Health ; Socioeconomic Factors ; surveillance ; survey ; Urban Health ; éradication</subject><ispartof>Tropical medicine & international health, 2006-06, Vol.11 (6), p.862-868</ispartof><rights>2006 INIST-CNRS</rights><rights>2006 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4746-8dee7a0cef52dccd1f3f171085b6c7c2c3e2ea224ecd09f8f30d187955217c9b3</citedby><cites>FETCH-LOGICAL-c4746-8dee7a0cef52dccd1f3f171085b6c7c2c3e2ea224ecd09f8f30d187955217c9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1417,1433,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17825130$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16772008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mathieu, Els</creatorcontrib><creatorcontrib>Direny, Abdel N.</creatorcontrib><creatorcontrib>De Rochars, Madsen Beau</creatorcontrib><creatorcontrib>Streit, Thomas G.</creatorcontrib><creatorcontrib>Addiss, David G.</creatorcontrib><creatorcontrib>Lammie, Patrick J.</creatorcontrib><title>Participation in three consecutive mass drug administrations in Leogane, Haiti</title><title>Tropical medicine & international health</title><addtitle>Trop Med Int Health</addtitle><description>Summary
Objectives In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non‐compliant and factors associated with this behaviour.
Methods We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non‐compliance and associated factors and (3) an urban survey to make a rural–urban comparison.
Results During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4–82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0–66.7), 61.0% (95% CI 55.0–67.4) and 67.3% (95% CI 60.5–74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the population >14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
Conclusion More research is needed to identify characteristics of systematically non‐compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
Objectifs Dans l'effort global d’élimination de la filariose lymphatique, des administrations massives de médicament ont été organisées annuellement. Le succès de cette stratégie dépend de l'atteinte d'un haut niveau de l’étendue de couverture médicamenteuse, ce qui réduira le nombre de personnes porteuses de microfilaires circulant et par conséquent réduira la transmission de la maladie. Les personnes qui ne participant pas à ces administrations massives de médicaments représentent une menace potentielle pour le but de l’élimination de la filariose. Nous avons voulu connaître l’étendue de la couverture médicamenteuse, la proportion de personnes systématiquement non compliantes et les facteurs associés au comportement de non compliance.
Méthodes Nous avons mené trois enquêtes à la suite de la troisième administration de masse annuelle de médicament d'un programme d’élimination de la filariose à Leogane en Haïti: 1) enquête sur la population totale pour déterminer l’étendue de la couverture, 2) enquête chez les adultes pour déterminer la non compliance et les facteurs associés et 3) enquête urbaine pour une comparaison entre le milieu rurale et urbain.
Résultats Au cours de la 3ieme administration en masse de médicament, la couverture totale était de 78,5% (IC95%: 74,4–82,6). Une enquête dans lapopulation adulte a révèle une couverture chez les plus de 14 ans estimée respectivement à 59,4% (IC95%: 52,0–66,7), 61,0% (IC95%: 55,0–67,4) et 67,3% (IC95%: 60,5–74,0) pour la 1ere, 2ieme et 3ieme administration en masse de médicament. La couverture dans les zones rurales (78,3%) était significativement plus élevée que dans les zones urbaines (68,3%, p < 0,05). 18% des plus de 14 ans n'avaient jamais pris les médicaments quelle que soit l'année. Ces derniers n’étaient pas significativement différents des autres participants par l’âge, le sexe ou autres caracteristiques évaluées.
Conclusion Des études supplémentaires sont nécessaires pour identifier les caracteristiques des personnes systématiquement non compliantes afin d'affiner les messages d’éducation et d'améliorer les stratégies de distribution pour augmenter l’étendue de la couverture.
Objetivos Como parte del esfuerzo global para eliminar la filariasis linfática, anualmente se organizar administraciones masivas de medicamentos (AMM). El éxito de esta estrategia depende del poder alcanzar niveles altos de cobertura de los medicamentos, que reduzcan el número de personas que circulan con microfilarias y por ende, la transmisión. Las personas que consistentemente fallan en participar de las AMM representan una amenaza potencial al objetivo de eliminar la filariasis. Queríamos averiguar cual era la cobertura de medicamentos, la proporción de personas que sistemáticamente no cumplían y los factores asociados a este comportamiento.
Métodos Se realizaron 3 encuestas tras la tercera AMM anual del programa para la eliminación de la filariasis, en Leogane, Haiti: 1/encuesta a la población total con el fin de determinar la cobertura 2/encuesta entre los adultos para determinar falta de cumplimiento y factores asociados y 3/encuesta urbana para establecer una comparación rural‐urbana.
Resultados Durante la tercera AMM, la cobertura total entre los encuestados fue del 78.5% (95% intervalo de confianza (IC) 74.4–82.6). Una encuesta entre la población adulta mostró estimativos de cobertura para mayores de 14 años del 59.4% (95% IC 52.0–66.7), 61.0% (95% CI 55.0–67.4) y 67.3% (95% CI 60.5–74.0), para el primer, segundo y tercer AMM respectivamente. La cobertura en áreas rurales (78.3%) fue significativamente mayor que en áreas urbanas (68.3%, p < 0.05). De la población < 14 años, el 18% no tomó medicamentos durante ninguna de las tres AMM. Estas personas no eran significativamente diferentes de quienes sí participaban de las AMM ni en edad, género o cualquier otra característica evaluada.
Conclusiones Se requieren más estudios para identificar las características de personas sistemáticamente no cumplidoras, con el fin de redefinir los mensajes de educación en salud y para mejorar las estrategias de distribución que aumenten la cobertura de medicamentos.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anthelmintics - adverse effects</subject><subject>Anthelmintics - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>community‐based distribution</subject><subject>Compliance</subject><subject>Diseases caused by nematodes</subject><subject>distribución basada en la comunidad</subject><subject>distribution basée sur la communauté</subject><subject>Drug therapy</subject><subject>Elephantiasis, Filarial - drug therapy</subject><subject>Elephantiasis, Filarial - epidemiology</subject><subject>encuesta</subject><subject>eradication</subject><subject>erradicación</subject><subject>Female</subject><subject>Filariases</subject><subject>filariasis linfática</subject><subject>filariose lymphatique</subject><subject>General aspects</subject><subject>Haiti - epidemiology</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Helminthic diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Lymphatic filariases</subject><subject>lymphatic filariasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Parasitic diseases</subject><subject>Patient Compliance - psychology</subject><subject>Patient Education as Topic - methods</subject><subject>Population Surveillance</subject><subject>Public health</subject><subject>Rural Health</subject><subject>Socioeconomic Factors</subject><subject>surveillance</subject><subject>survey</subject><subject>Urban Health</subject><subject>éradication</subject><issn>1360-2276</issn><issn>1365-3156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkD1PwzAQhi0EolD4CyhCYiPBdmI7HRhQBbRS-RjKbLn2pThqkmIn0P57kjaiK7fcSX7eO-tBKCA4Im3d5RGJOQtjwnhEMeYRJpzyaHOEzv4ejnczDikVfIDOvc8xxknC-CkaEC5Em0vP0Ou7crXVdq1qW5WBLYP60wEEuio96Ka23xAUyvvAuGYZKFPY0vra7Wjf4TOolqqE22CibG0v0EmmVh4u-z5EH0-P8_EknL09T8cPs1AnIuFhagCEwhoyRo3WhmRxRgTBKVtwLTTVMVBQlCagDR5laRZjQ1IxYowSoUeLeIiu93vXrvpqwNcyrxpXticlJYxhkXLeQuke0q7y3kEm184Wym0lwbLzKHPZ6ZKdLtl5lDuPctNGr_r9zaIAcwj24lrgpgeU12qVOVVq6w-cSCkjMW65-z33Y1ew_fcH5Pxl2k3xL1_pjkg</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Mathieu, Els</creator><creator>Direny, Abdel N.</creator><creator>De Rochars, Madsen Beau</creator><creator>Streit, Thomas G.</creator><creator>Addiss, David G.</creator><creator>Lammie, Patrick J.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope></search><sort><creationdate>200606</creationdate><title>Participation in three consecutive mass drug administrations in Leogane, Haiti</title><author>Mathieu, Els ; Direny, Abdel N. ; De Rochars, Madsen Beau ; Streit, Thomas G. ; Addiss, David G. ; Lammie, Patrick J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4746-8dee7a0cef52dccd1f3f171085b6c7c2c3e2ea224ecd09f8f30d187955217c9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anthelmintics - adverse effects</topic><topic>Anthelmintics - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>community‐based distribution</topic><topic>Compliance</topic><topic>Diseases caused by nematodes</topic><topic>distribución basada en la comunidad</topic><topic>distribution basée sur la communauté</topic><topic>Drug therapy</topic><topic>Elephantiasis, Filarial - drug therapy</topic><topic>Elephantiasis, Filarial - epidemiology</topic><topic>encuesta</topic><topic>eradication</topic><topic>erradicación</topic><topic>Female</topic><topic>Filariases</topic><topic>filariasis linfática</topic><topic>filariose lymphatique</topic><topic>General aspects</topic><topic>Haiti - epidemiology</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Helminthic diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Lymphatic filariases</topic><topic>lymphatic filariasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Parasitic diseases</topic><topic>Patient Compliance - psychology</topic><topic>Patient Education as Topic - methods</topic><topic>Population Surveillance</topic><topic>Public health</topic><topic>Rural Health</topic><topic>Socioeconomic Factors</topic><topic>surveillance</topic><topic>survey</topic><topic>Urban Health</topic><topic>éradication</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathieu, Els</creatorcontrib><creatorcontrib>Direny, Abdel N.</creatorcontrib><creatorcontrib>De Rochars, Madsen Beau</creatorcontrib><creatorcontrib>Streit, Thomas G.</creatorcontrib><creatorcontrib>Addiss, David G.</creatorcontrib><creatorcontrib>Lammie, Patrick J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Tropical medicine & international health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathieu, Els</au><au>Direny, Abdel N.</au><au>De Rochars, Madsen Beau</au><au>Streit, Thomas G.</au><au>Addiss, David G.</au><au>Lammie, Patrick J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Participation in three consecutive mass drug administrations in Leogane, Haiti</atitle><jtitle>Tropical medicine & international health</jtitle><addtitle>Trop Med Int Health</addtitle><date>2006-06</date><risdate>2006</risdate><volume>11</volume><issue>6</issue><spage>862</spage><epage>868</epage><pages>862-868</pages><issn>1360-2276</issn><eissn>1365-3156</eissn><abstract>Summary
Objectives In the global effort to eliminate lymphatic filariasis, mass drug administrations (MDAs) are organised annually. The success of this strategy depends on achieving high levels of drug coverage, which reduce the number of persons with circulating microfilariae and consequently transmission. Persons who consistently fail to participate in MDAs represent a potential threat to the goal of filariasis elimination. We wanted to know the drug coverage, the proportion of persons who were systematically non‐compliant and factors associated with this behaviour.
Methods We conducted three surveys following the third annual MDA of a filariasis elimination program in Leogane, Haiti: (1) a total population survey to determine coverage; (2) an adult survey to determine non‐compliance and associated factors and (3) an urban survey to make a rural–urban comparison.
Results During the third MDA, the overall surveyed coverage was 78.5% [95% confidence interval (CI) 74.4–82.6] A survey among adult population showed coverage estimates for persons >14 years old of 59.4% (95% CI 52.0–66.7), 61.0% (95% CI 55.0–67.4) and 67.3% (95% CI 60.5–74.0), for the first, second and third MDA respectively. The coverage in rural areas (78.3%) was significantly higher than in urban areas (68.3%, P < 0.05). Of the population >14 years of age, 18% never took the drugs during any of three MDAs. These persons did not differ significantly from MDA participants by age, gender or other characteristics that we assessed.
Conclusion More research is needed to identify characteristics of systematically non‐compliant persons in order to refine health education messages and improve distribution strategies to increase drug coverage.
Objectifs Dans l'effort global d’élimination de la filariose lymphatique, des administrations massives de médicament ont été organisées annuellement. Le succès de cette stratégie dépend de l'atteinte d'un haut niveau de l’étendue de couverture médicamenteuse, ce qui réduira le nombre de personnes porteuses de microfilaires circulant et par conséquent réduira la transmission de la maladie. Les personnes qui ne participant pas à ces administrations massives de médicaments représentent une menace potentielle pour le but de l’élimination de la filariose. Nous avons voulu connaître l’étendue de la couverture médicamenteuse, la proportion de personnes systématiquement non compliantes et les facteurs associés au comportement de non compliance.
Méthodes Nous avons mené trois enquêtes à la suite de la troisième administration de masse annuelle de médicament d'un programme d’élimination de la filariose à Leogane en Haïti: 1) enquête sur la population totale pour déterminer l’étendue de la couverture, 2) enquête chez les adultes pour déterminer la non compliance et les facteurs associés et 3) enquête urbaine pour une comparaison entre le milieu rurale et urbain.
Résultats Au cours de la 3ieme administration en masse de médicament, la couverture totale était de 78,5% (IC95%: 74,4–82,6). Une enquête dans lapopulation adulte a révèle une couverture chez les plus de 14 ans estimée respectivement à 59,4% (IC95%: 52,0–66,7), 61,0% (IC95%: 55,0–67,4) et 67,3% (IC95%: 60,5–74,0) pour la 1ere, 2ieme et 3ieme administration en masse de médicament. La couverture dans les zones rurales (78,3%) était significativement plus élevée que dans les zones urbaines (68,3%, p < 0,05). 18% des plus de 14 ans n'avaient jamais pris les médicaments quelle que soit l'année. Ces derniers n’étaient pas significativement différents des autres participants par l’âge, le sexe ou autres caracteristiques évaluées.
Conclusion Des études supplémentaires sont nécessaires pour identifier les caracteristiques des personnes systématiquement non compliantes afin d'affiner les messages d’éducation et d'améliorer les stratégies de distribution pour augmenter l’étendue de la couverture.
Objetivos Como parte del esfuerzo global para eliminar la filariasis linfática, anualmente se organizar administraciones masivas de medicamentos (AMM). El éxito de esta estrategia depende del poder alcanzar niveles altos de cobertura de los medicamentos, que reduzcan el número de personas que circulan con microfilarias y por ende, la transmisión. Las personas que consistentemente fallan en participar de las AMM representan una amenaza potencial al objetivo de eliminar la filariasis. Queríamos averiguar cual era la cobertura de medicamentos, la proporción de personas que sistemáticamente no cumplían y los factores asociados a este comportamiento.
Métodos Se realizaron 3 encuestas tras la tercera AMM anual del programa para la eliminación de la filariasis, en Leogane, Haiti: 1/encuesta a la población total con el fin de determinar la cobertura 2/encuesta entre los adultos para determinar falta de cumplimiento y factores asociados y 3/encuesta urbana para establecer una comparación rural‐urbana.
Resultados Durante la tercera AMM, la cobertura total entre los encuestados fue del 78.5% (95% intervalo de confianza (IC) 74.4–82.6). Una encuesta entre la población adulta mostró estimativos de cobertura para mayores de 14 años del 59.4% (95% IC 52.0–66.7), 61.0% (95% CI 55.0–67.4) y 67.3% (95% CI 60.5–74.0), para el primer, segundo y tercer AMM respectivamente. La cobertura en áreas rurales (78.3%) fue significativamente mayor que en áreas urbanas (68.3%, p < 0.05). De la población < 14 años, el 18% no tomó medicamentos durante ninguna de las tres AMM. Estas personas no eran significativamente diferentes de quienes sí participaban de las AMM ni en edad, género o cualquier otra característica evaluada.
Conclusiones Se requieren más estudios para identificar las características de personas sistemáticamente no cumplidoras, con el fin de redefinir los mensajes de educación en salud y para mejorar las estrategias de distribución que aumenten la cobertura de medicamentos.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16772008</pmid><doi>10.1111/j.1365-3156.2006.01626.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1360-2276 |
| ispartof | Tropical medicine & international health, 2006-06, Vol.11 (6), p.862-868 |
| issn | 1360-2276 1365-3156 |
| language | eng |
| recordid | cdi_proquest_journals_215507866 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; IngentaConnect Free/Open Access Journals; Wiley Online Library (Open Access Collection) |
| subjects | Adolescent Adult Aged Aged, 80 and over Anthelmintics - adverse effects Anthelmintics - therapeutic use Biological and medical sciences Child Child, Preschool community‐based distribution Compliance Diseases caused by nematodes distribución basada en la comunidad distribution basée sur la communauté Drug therapy Elephantiasis, Filarial - drug therapy Elephantiasis, Filarial - epidemiology encuesta eradication erradicación Female Filariases filariasis linfática filariose lymphatique General aspects Haiti - epidemiology Health Knowledge, Attitudes, Practice Helminthic diseases Humans Infant Infectious diseases Lymphatic filariases lymphatic filariasis Male Medical sciences Middle Aged Parasitic diseases Patient Compliance - psychology Patient Education as Topic - methods Population Surveillance Public health Rural Health Socioeconomic Factors surveillance survey Urban Health éradication |
| title | Participation in three consecutive mass drug administrations in Leogane, Haiti |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T04%3A56%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Participation%20in%20three%20consecutive%20mass%20drug%20administrations%20in%20Leogane,%20Haiti&rft.jtitle=Tropical%20medicine%20&%20international%20health&rft.au=Mathieu,%20Els&rft.date=2006-06&rft.volume=11&rft.issue=6&rft.spage=862&rft.epage=868&rft.pages=862-868&rft.issn=1360-2276&rft.eissn=1365-3156&rft_id=info:doi/10.1111/j.1365-3156.2006.01626.x&rft_dat=%3Cproquest_cross%3E1050065701%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215507866&rft_id=info:pmid/16772008&rfr_iscdi=true |